CDC-501

· Celgene

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CDC-501, covering 2019-11-12 to 2019-11-12. Get the full timeline:

Most recent: Clinical Trial Update: CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma [Phase 2]